US 10196613
Stem cells for modeling type 2 diabetes
granted A61KA61K35/39A61K35/545
Quick answer
US patent 10196613 (Stem cells for modeling type 2 diabetes) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/39, A61K35/545